Biot-GRSRSRSRSRSR-NH2

Ref. 3D-PP46260

Product Information

• Name: Biot-GRSRSRSRSRSR-NH2
• Synonyms: Biot-Gly-Arg-Ser-Arg-Ser-Arg-Ser-Arg-Ser-Arg-Ser-Arg-amide

Description

Peptide Biot-GRSRSRSRSRSR-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Biot-GRSRSRSRSRSR-NH2 include the following: Synthesis of N, N0-bis (5-arylidene-4-oxo-3, 5-dihydro-4H-imidazol-2-yl) diamines bearing various linkers and biological evaluation as potential inhibitors of WK Coulibalya, L Paquin, A Benie - European Journal of , 2012 - academia.eduhttps://www.academia.edu/download/45427486/Synthesis_of_NN_-bis5-arylidene-4-oxo-20160507-15074-3kxdr4.pdf Synthesis and biological evaluation of Haspin inhibitors: Kinase inhibitory potency and cellular activity W Zeinyeh, YJ Esvan, B Josselin, M Defois - European Journal of , 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0223523422002719 Combined virtual and experimental screening for CK1 inhibitors identifies a modulator of p53 and reveals important aspects of in silico screening performance V Myrianthopoulos , O Lozach , D Zareifi - International Journal of , 2017 - mdpi.comhttps://www.mdpi.com/1422-0067/18/10/2102 Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid T Tahtouh , JM Elkins, P Filippakopoulos - Journal of medicinal , 2012 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/jm301034u Structure-based virtual screening, biological assessment, and MD simulation studies of novel CNS compatible GSK-3beta inhibitors as potential Alzheimer's disease S Sukanya, BS Choudhary , P Mehta, S Filipek , R Malik - 2022 - researchsquare.comhttps://www.researchsquare.com/article/rs-1309750/latest Library-based discovery of DYRK1A/CLK1 inhibitors from natural product extracts P Grabher, E Durieu, E Kouloura, M Halabalaki - Planta , 2012 - thieme-connect.comhttps://www.thieme-connect.com/products/ejournals/html/10.1055/s-0031-1298625 Solene Guiheneuf, Ludovic Paquin, Franaca§ois Carreaux, Emilie Durieu, Thierry Roisnel, Laurent Meijer & Jean P Bazureau - Mol Divers, 2014 - researchgate.nethttps://www.researchgate.net/profile/Laurent-Meijer/publication/260445612_New_5-ylidene_rhodanine_derivatives_based_on_the_dispacamide_A_model/links/00b7d53a74286cb95a000000/New-5-ylidene-rhodanine-derivatives-based-on-the-dispacamide-A-model.pdf In vitro identification of imidazo [1, 2-a] pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition MA Bazin, S Cojean , F Pagniez, G Bernadat - European Journal of , 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0223523420309284 Discovery of novel (imidazo [1, 2-a] pyrazin-6-yl) ureas as antiproliferative agents targeting P53 in non-small cell lung cancer cell lines MA Bazin, B Rousseau , S Marhadour - Anticancer , 2016 - ar.iiarjournals.orghttps://ar.iiarjournals.org/content/36/4/1621.short Synthesis and Kinase Inhibitory Potencies of Pyrazolo[3,4-g]isoquinolines M Defois, C Remondin, B Josselin, L Nauton , V Thery - Molecules, 2022 - mdpi.comhttps://www.mdpi.com/1420-3049/27/17/5578 Synthesis and biological evaluation of 1H-pyrrolo [3, 2-g] isoquinolines M Defois, B Josselin, P Brindeau, A Kramer - Bioorganic & Medicinal , 2024 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0968089624000336 New pyrido [3, 4-g] quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis H Tazarki, W Zeinyeh, YJ Esvan, S Knapp - European Journal of , 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S022352341930056X Chemical synthesis and biological validation of immobilized protein kinase inhibitory Leucettines G Burgy, T Tahtouh , E Durieu, B Foll-Josselin - European Journal of , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0223523413000639 Synthesis and biological studies of new quinazolines with ether functions in position 2 D Brahmaiah, AKD Bhavani, P Aparna - -Online Journal of , 2019 - univ-rennes.hal.sciencehttps://univ-rennes.hal.science/hal-02161844/ Structure Activity Relationship Studies around DB18, a Potent and Selective Inhibitor of CLK Kinases D Brahmaiah, AKD Bhavani, P Aparna , NS Kumar - Molecules, 2022 - mdpi.comhttps://www.mdpi.com/1420-3049/27/19/6149 New quinoxaline derivatives as dual Pim-1/2 kinase inhibitors: Design, synthesis and biological evaluation B Oyallon, M Brachet-Botineau, C Loge, T Robert - Molecules, 2021 - mdpi.comhttps://www.mdpi.com/1420-3049/26/4/867 Biological evaluation of arylsemicarbazone derivatives as potential anticancer agents ACN da Cruz, DJ Brondani, I Temaca­stocles - , 2019 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958387/ Biological evaluation of arylsemicarbazone derivatives as potential anticancer agents AC Nascimento da Cruz, DJ Brondani - Pharmaceuticals, 2019 - mdpi.comhttps://www.mdpi.com/1424-8247/12/4/169

• Brand: Biosynth